Greve Katrine B V, Lindgreen Jonas N, Terp Mikkel G, Pedersen Christina B, Schmidt Steffen, Mollenhauer Jan, Kristensen Stine B, Andersen Rikke S, Relster Mette M, Ditzel Henrik J, Gjerstorff Morten F
Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, DK-5000 Odense, Denmark.
Department of Cancer and Inflammation Research, Institute for Molecular Medicine, University of Southern Denmark, DK-5000 Odense, Denmark; The Lundbeckfonden Center of Excellence NanoCAN, University of Southern Denmark, DK-5000 Odense, Denmark.
Mol Oncol. 2015 Feb;9(2):437-49. doi: 10.1016/j.molonc.2014.09.001. Epub 2014 Oct 6.
SSX cancer/testis antigens are frequently expressed in melanoma tumors and represent attractive targets for immunotherapy, but their role in melanoma tumorigenesis has remained elusive. Here, we investigated the cellular effects of SSX2 expression. In A375 melanoma cells, SSX2 expression resulted in an increased DNA content and enlargement of cell nuclei, suggestive of replication aberrations. The cells further displayed signs of DNA damage and genomic instability, associated with p53-mediated G1 cell cycle arrest and a late apoptotic response. These results suggest a model wherein SSX2-mediated replication stress translates into mitotic defects and genomic instability. Arrest of cell growth and induction of DNA double-strand breaks was also observed in MCF7 breast cancer cells in response to SSX2 expression. Additionally, MCF7 cells with ectopic SSX2 expression demonstrated typical signs of senescence (i.e. an irregular and enlarged cell shape, enhanced β-galactosidase activity and DNA double-strand breaks). Since replication defects, DNA damage and senescence are interconnected and well-documented effects of oncogene expression, we tested the oncogenic potential of SSX2. Importantly, knockdown of SSX2 expression in melanoma cell lines demonstrated that SSX2 supports the growth of melanoma cells. Our results reveal two important phenotypes of ectopic SSX2 expression that may drive/support tumorigenesis: First, immediate induction of genomic instability, and second, long-term support of tumor cell growth.
SSX癌胚抗原在黑色素瘤肿瘤中频繁表达,是免疫治疗的诱人靶点,但其在黑色素瘤肿瘤发生中的作用仍不清楚。在此,我们研究了SSX2表达的细胞效应。在A375黑色素瘤细胞中,SSX2表达导致DNA含量增加和细胞核增大,提示复制异常。这些细胞进一步表现出DNA损伤和基因组不稳定的迹象,与p53介导的G1期细胞周期停滞和晚期凋亡反应相关。这些结果提示了一种模型,其中SSX2介导的复制应激转化为有丝分裂缺陷和基因组不稳定。在MCF7乳腺癌细胞中,响应SSX2表达也观察到细胞生长停滞和DNA双链断裂的诱导。此外,异位表达SSX2的MCF7细胞表现出典型的衰老迹象(即细胞形状不规则且增大、β-半乳糖苷酶活性增强和DNA双链断裂)。由于复制缺陷、DNA损伤和衰老是癌基因表达相互关联且有充分记录的效应,我们测试了SSX2的致癌潜力。重要的是,在黑色素瘤细胞系中敲低SSX2表达表明SSX2支持黑色素瘤细胞的生长。我们的结果揭示了异位表达SSX2可能驱动/支持肿瘤发生的两个重要表型:第一,立即诱导基因组不稳定,第二,长期支持肿瘤细胞生长。